Bayesian Capital Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-3,306
| Closed | -$1.17M | – | 980 |
|
|
2024
Q4 | $1.17M | Buy |
+3,306
| New | +$1.17M | 0.14% | 211 |
|
|
2024
Q2 | – | Sell |
-3,360
| Closed | -$772K | – | 1115 |
|
|
2024
Q1 | $772K | Buy |
+3,360
| New | +$772K | 0.07% | 340 |
|
|
2023
Q1 | – | Sell |
-1,542
| Closed | -$429K | – | 1104 |
|
|
2022
Q4 | $429K | Buy |
+1,542
| New | +$429K | 0.06% | 396 |
|
|
2022
Q3 | – | Sell |
-9,500
| Closed | -$2.24M | – | 1031 |
|
|
2022
Q2 | $2.24M | Buy |
9,500
+7,800
| +459% | +$1.84M | 0.42% | 32 |
|
|
2022
Q1 | $305K | Buy |
+1,700
| New | +$305K | 0.05% | 514 |
|
|
2020
Q1 | – | Sell |
-2,621
| Closed | -$231K | – | 988 |
|
|
2019
Q4 | $231K | Buy |
+2,621
| New | +$231K | 0.04% | 494 |
|
|
2019
Q3 | – | Sell |
-12,376
| Closed | -$966K | – | 697 |
|
|
2019
Q2 | $966K | Buy |
+12,376
| New | +$966K | 0.2% | 146 |
|
|
2018
Q1 | – | Sell |
-4,600
| Closed | -$681K | – | 830 |
|
|
2017
Q4 | $681K | Buy |
+4,600
| New | +$681K | 0.14% | 249 |
|
|
2016
Q1 | – | Sell |
-2,003
| Closed | -$314K | – | 446 |
|
|
2015
Q4 | $314K | Buy |
+2,003
| New | +$314K | 0.45% | 88 |
|